Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Toxicol Appl Pharmacol ; : 117037, 2024 Jul 12.
Artigo em Inglês | MEDLINE | ID: mdl-39004143

RESUMO

BACKGROUND: Fibromyalgia (FM) is a complex syndrome with somatic symptoms connected to the operational state of muscles. Although radiotherapy is a cornerstone in cancer treatment, it is implicated in the aggravation of FM. Lately, formulation of medicines in nano-forms become of great prominence due to their prospective applications in medicine. So, this study aimed to assess possible therapeutic benefits of formulating pregabalin in a nono-form (N-PG) for managing FM during exposure to gamma radiation. METHODS: Gamma rays administered in fractionated doses (2 Gy/day) to male rats after one hour of s.c. injection of reserpine (1 mL/kg per day) to induce FM, then treated with single daily dose of (30 mg/kg, p.o.) PG or N-PG for ten successive days. Rats were subjected to behavioral tests, then sacrificed to obtain serum and gastrocnemius muscles. RESULTS: N-PG significantly antagonized reserpine-induced FM as proved by; the immobility and performance times in forced swim and rotarod performance tests, respectively were restored near to the normal time, serum IL-8 and MCP-1 chemokines were nearby the normal levels, mitigated oxidative stress through increasing total thiol, Sirt3, CAT enzyme and decreasing COX-1, inhibition of inflammation via IL-1ß and MIF significant reduction, it possessed anti-apoptotic effect verified by decreasing PARP-1 and increasing Bcl-XL, gastrocnemius muscles had minimal fibrosis levels as seen after Masson trichrome staining. Histopathological results were coincidence with biochemical inspection. CONCLUSION: This study identifies N-PG as a novel drug that could be of a value in the management of FM particularly in cancer patients undergoing radiotherapy.

2.
Int J Radiat Biol ; 99(9): 1463-1472, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-35647928

RESUMO

BACKGROUND AND OBJECTIVES: Brain damage which has been induced by radiation generally occurs in radiotherapeutics patients. Stem cell transplantation represents a vital applicant for alleviating neurodegenerative disorders. This work aims at exploring the potential of bone marrow-derived mesenchymal stem cells (BM-MSCs) on brain injury induced by γ radiation in mice and the possible underlying mechanisms were elucidated. MATERIALS AND METHODS: Mice were allocated into three groups; Group I (Control), Group II (Irradiated control) where mice submitted to 5 Gy of whole-body γ radiation, Group III (Irradiated + BM-MSCs) where mice were intravenously injected of BM-MSCs at a dose of 106 cells/mice 24 h following irradiation. Animals were sacrificed 28 d following exposure to γ radiation. RESULTS: It was observed that BM-MSCs therapy provided a valuable tissue repair as evidenced by a reduction in inflammatory mediators including tumor necrosis factor alpha (TNF-α), interleukin-1ß (IL-1ß), nuclear factor kappa (NF-κß), phosphorylated NF-κß-p65 (P-NF-κß-p65), interferon-gamma (IFNγ) and monocyte chemoattractant protein-1 (MCP-1) associated with decreased levels of transforming growth factor-ß (TGF-ß) and vascular endothelial growth factor (VEGF) in brain tissues of irradiated mice. Furthermore, neuronal apoptosis was declined in brain tissues of the BM-MSCs group as remarkable inhibition of caspase-3 and Bax accompanied by elevation of Bcl-2 proteins expression. These results were supported by histopathological investigation. CONCLUSIONS: In conclusion, BM-MSCs could display a vital rule in alleviating brain injury in radio-therapeutic patients.


Assuntos
Lesões Encefálicas , Células-Tronco Mesenquimais , Camundongos , Animais , Fator A de Crescimento do Endotélio Vascular , Células-Tronco Mesenquimais/metabolismo , Anti-Inflamatórios , Lesões Encefálicas/etiologia , Lesões Encefálicas/terapia , Encéfalo/metabolismo
3.
Arch Biochem Biophys ; 731: 109431, 2022 11 30.
Artigo em Inglês | MEDLINE | ID: mdl-36243140

RESUMO

PURPOSE: To synthesize a polymeric pH-sensitive nanocarrier for the delivery of pyrogallol and investigate the anti-tumor activity of pyrogallol-loaded polymeric nanogel against colon cancer in rats. METHODS: Poly(ethylene glycol)/polyacrylic acid (PEG/PAAc) nanogel was performed using gamma irradiation technique at irradiation doses; 30,40, and 50 kGy. The particle size distribution and diameter were investigated under the influence of various parameters by using dynamic light scattering analysis (DLS). The particle size was diminished by increasing AAc content and irradiation dose. Characterization of the performed nanogel was performed by (FT-IR) and (TEM). In vitro drug release behavior of the nanogel towards pyrogallol drug was assessed. Furthermore, the anti-cancer therapeutic efficiency of pyrogallol loaded PEG/PAAc nanogel was evaluated in a chemically induced colon cancer model in rats. RESULTS: Pyrogallol/PEG/PAAc significantly reduced tumor incidence and volume as compared to DMH group. Also, it activated apoptotic pathway via up-regulating Bax, cytochrome C, cleaved caspase-3, p53, and down-regulating Bcl-2 expression. Furthermore, it attenuated cell cycle progression via reducing Cyclin A, Cyclin D1, and Cyclin E expression. It exhibited anti-proliferative activity through inhibiting PI3K/AKT signaling and downregulating the phosphorylation of AKT. It reduced pro-inflammatory cytokines TNF-α and IL-6. Results were confirmed by histopathological examination of colonic tissue. Interestingly, pyrogallol/PEG/PAAc demonstrated anti-tumor potential more efficiently than free pyrogallol, revealing localized drug delivery. CONCLUSION: This formulation could be considered as a promising agent in the treatment of colon cancer.


Assuntos
Neoplasias do Colo , Pirogalol , Ratos , Animais , Nanogéis , Pirogalol/farmacologia , Fosfatidilinositol 3-Quinases , Proteínas Proto-Oncogênicas c-akt , Espectroscopia de Infravermelho com Transformada de Fourier , Polímeros/química , Polietilenoglicóis/química , Neoplasias do Colo/tratamento farmacológico , Concentração de Íons de Hidrogênio
4.
Eur J Pharm Sci ; 167: 106002, 2021 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-34517108

RESUMO

Radiation-induced enteropathy is a major clinical challenge during radiotherapy. Resveratrol displays beneficial pharmacological activities; however, low oral bioavailability limits its effectiveness. This study aims at preparing methacrylic acid (MAAc) functionalized multi-walled carbon nanotubes (MWCNTs-MAAc) as carriers for pH triggered controlled release of resveratrol in an effort to improve the drug therapeutic potential. MWCNTs-MAAc were prepared using radiation technique and then characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), scanning electron microscope (SEM), X-ray diffraction (XRD) and Fourier transform-infrared (FT-IR) spectroscopy. In vitro drug release profile at different pH values was analyzed. Furthermore, the designed RES-MWCNTs-MAAc nanocomplex was evaluated against radiation-induced enteropathy in rats. Oral administration of RES-MWCNTs-MAAc restored colonic redox state and elevated antioxidant enzymes activities glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) and reduced colonic inflammatory mediators tumor necrosis factor-α (TNF-α), interleukin-1ß (IL-1ß) and interferone-γ (IFN-γ) contents in addition to declining the intrinsic apoptotic pathway as evidenced by down-regulation of Bax and caspase-3 proteins expression accompanied by up-regulation of Bcl-2 protein expression. RES-MWCNTs-MAAc was more efficient than free resveratrol due to the delivery system that allowed prolonged resveratrol release at target site. Thus, this formulation could serve as a beneficial anti-inflammatory approach for patients during radiotherapy.


Assuntos
Nanotubos de Carbono , Animais , Antioxidantes , Catalase , Humanos , Ratos , Resveratrol , Espectroscopia de Infravermelho com Transformada de Fourier
5.
Drug Deliv Transl Res ; 11(1): 261-278, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-32488816

RESUMO

The current study aimed to investigate the ability of chitosan/poly (acrylic acid) nanogel (CAN) to improve the bioavailability and anticancer potential of rutin. Synthesis of CAN was carried out by gamma radiation-induced polymerization of acrylic acid in an aqueous solution of chitosan. The relationship between the hydrodynamic radius of CAN and the absorbed radiation doses was also investigated. The prepared nanogels were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), X-ray diffraction (XRD), and Fourier transform infrared (FT-IR) techniques, and then, it was used as a nano-drug carrier for rutin. The developed formulation was evaluated for its antitumor activity against chemically induced hepatocarcinoma in rats. The following parameters were measured: aspartate and alanine aminotransferase, alkaline phosphatase, gamma glutamyltransferase, and total bilirubin as liver function test; vascular endothelial growth factor as an angiogenesis marker; α-fetoprotein as a tumor marker; and P53, caspase-3, Bax, and Bcl-2 as apoptosis markers. Histopathological examination was also confirmed. Significant enhanced anti-proliferative, anti-angiogenic, and apoptotic effects were observed for rutin-loaded CAN than free rutin, indicating that this formulation could provide a novel therapeutic approach to serve as a promising agent for treatment of hepatocellular carcinoma. Graphical abstract.


Assuntos
Carcinoma Hepatocelular , Quitosana , Neoplasias Hepáticas , Acrilatos , Animais , Carcinoma Hepatocelular/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Nanogéis , Polietilenoglicóis , Polietilenoimina , Ratos , Rutina , Espectroscopia de Infravermelho com Transformada de Fourier
6.
Environ Toxicol ; 35(10): 1137-1145, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32463565

RESUMO

The low dose of radiation (LDR) has received growing attention for its beneficial neuroprotective effect. This study was designed to investigate the enhancing effect of LDR on the antidepressant potential of resveratrol against diazepam-induced depression in mice. Female mice divided into five groups; control, diazepam (2 mg/kg), LDR (0.5Gy) + diazepam, resveratrol (20 mg/kg) + diazepam, LDR + resveratrol+diazepam. Mice received diazepam showed depressive symptoms as evidenced by decreased locomotor activity in the open field and increased immobility time in the forced swimming and tail suspension tests integrated with a marked decline in biogenic amines (serotonin, norepinephrine, and dopamine) in brain tissues. These effects were ameliorated by LDR or resveratrol administration demonstrating an antidepressant activity. Interestingly, LDR triggered the antidepressant effect of resveratrol as it restored the changes in behavioral tests, neurotransmitters, and neuro-histoarchitecture. In conclusion, these findings suggested that LDR could be considered as a novel adjuvant that augmented the resveratrol antidepressant effect and might serve as a potential therapeutic approach for depression.


Assuntos
Antidepressivos/farmacologia , Comportamento Animal , Química Encefálica , Depressão/tratamento farmacológico , Raios gama , Fármacos Neuroprotetores/farmacologia , Resveratrol/farmacologia , Animais , Antidepressivos/uso terapêutico , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/efeitos da radiação , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Encéfalo/efeitos da radiação , Química Encefálica/efeitos dos fármacos , Química Encefálica/efeitos da radiação , Feminino , Elevação dos Membros Posteriores , Masculino , Camundongos , Atividade Motora/efeitos dos fármacos , Atividade Motora/efeitos da radiação , Fármacos Neuroprotetores/uso terapêutico , Neurotransmissores/metabolismo , Doses de Radiação , Resveratrol/uso terapêutico , Irradiação Corporal Total
7.
Clin Exp Pharmacol Physiol ; 47(2): 263-273, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31664738

RESUMO

The objective of this work was to evaluate the effect of a bradykinin-potentiating factor (BPF) isolated from Leiurus quinquestriatus scorpion venom as a natural modulator of radiation-induced cardiac damage. Four groups of rats were treated as follows; control group, group receiving BPF (1 µg/g b.wt i.p./biweekly) for 4 weeks, group irradiated at 6 Gy, group receiving BPF post-irradiation for 4 weeks. Irradiation induced a significant elevation of myocardial parameters: atrial natriuretic peptide (ANP), cardiac troponin I (cTnI), potassium (K+ ) and creatine kinase (CK); vascular indices: lactate dehydrogenase (LDH), inducible nitric oxide synthase (iNOS) and endothelin I; oxidative stress indices: malondialdehyde (MDA) associated with a significant depletion of both reduced glutathione (GSH) in the cardiac tissue homogenate and serum ferric reducing antioxidant power (FRAP) depletion and significantly reinforced elevation of Renin Angiotensin Aldosterone System (RAAS) indices: serum angiotensin II (AngII) and aldosterone, and also protein expression of cleaved caspase-3 and cyclophilin A. BPF administration altered the biochemical damage of radiation, specifically inhibited AngII formation, aldosterone release and prevented the histopathological and immunohistochemical alterations which were observed in cardiac tissue with significant reduction in mean arterial blood pressure (MAP) caused by irradiation. In conclusion, biochemical assays, histopathological and immunohistochemical findings of the present study demonstrated that exogenous BPF isolated from scorpion venom reduced the cardiomyopathy alterations induced by irradiation via remodelling of the RAAS pathway.


Assuntos
Cardiomiopatias/tratamento farmacológico , Raios gama/efeitos adversos , Oligopeptídeos/uso terapêutico , Sistema Renina-Angiotensina/efeitos dos fármacos , Venenos de Escorpião/uso terapêutico , Animais , Cardiomiopatias/metabolismo , Cardiomiopatias/patologia , Masculino , Oligopeptídeos/isolamento & purificação , Oligopeptídeos/farmacologia , Ratos , Ratos Wistar , Sistema Renina-Angiotensina/fisiologia , Sistema Renina-Angiotensina/efeitos da radiação , Venenos de Escorpião/isolamento & purificação , Venenos de Escorpião/farmacologia
8.
Environ Toxicol ; 35(2): 223-230, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31633274

RESUMO

Radiation-induced enteritis is one of the greatest challenges in radiotherapy. The current study was designed to evaluate the ameliorative effect of resveratrol, which exhibits anti-inflammatory property, against radiation-induced intestinal injury in rats and to explore the underlying mechanism. Rats were exposed to a single dose of 5 Gy. Resveratrol (20 mg/kg/day) was orally administered to irradiated rats over 3 weeks. Results showed that resveratrol ameliorated the intestinal oxidative stress parameters; malondialdehyde (MDA) content, glutathione (GSH) level, and catalase (CAT) activity compared to irradiated group. Furthermore, resveratrol reduced the contents of inflammatory cytokines; tumor necrosis factor α (TNF-α), nuclear factor-kappa (NF-κB), and interleukin 1ß (IL-1ß) in intestine. Western blotting analysis revealed that resveratrol down-regulated the proteins expression of phosphoinositide 3-kinases (PI3K), protein kinase B (Akt) as well as the mammalian target of rapamycin (mTOR) in intestinal tissues of irradiated rats and thus reduced the inflammatory mediator production. These results were confirmed by histopathological investigation. In conclusion, resveratrol attenuated intestinal inflammation following irradiation via modulating PI3K/Akt/mTOR pathway and thereby could be a promising adjuvant in radiotherapy.


Assuntos
Anti-Inflamatórios/farmacologia , Intestinos/efeitos da radiação , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Lesões Experimentais por Radiação/prevenção & controle , Resveratrol/farmacologia , Serina-Treonina Quinases TOR/metabolismo , Animais , Raios gama , Inflamação , Intestinos/imunologia , Masculino , NF-kappa B/metabolismo , Estresse Oxidativo/imunologia , Estresse Oxidativo/efeitos da radiação , Lesões Experimentais por Radiação/imunologia , Lesões Experimentais por Radiação/metabolismo , Ratos , Transdução de Sinais/efeitos dos fármacos , Fator de Necrose Tumoral alfa/metabolismo
9.
Planta Med ; 86(1): 61-69, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31627218

RESUMO

Opuntia ficus-indica extract has been used in traditional folk medicine for several purposes and exhibits anti-inflammatory properties. This study was directed to explore the prophylactic effect of O. ficus-indica fruit peel extract against irradiation-induced colitis in rats. GC/MS analysis of the petroleum ether extract led to recognition of 33 compounds in the unsaponifiable fraction and 15 fatty acid methyl esters in the saponifiable part. Thirteen terpenes and sterols were isolated and identified from which ten compounds were not isolated from any part of this species before. Data showed that irradiation induced colon injury as manifested by elevated contents of malondialdehyde, nitric oxide, myeloperoxidase, intercellular adhesion molecule-1, cyclooxygenase-2, tumor necrosis factor alpha, and nuclear factor kappa B, while it reduced superoxide dismutase activity and interleukin 10 content in colonic tissues, which was confirmed by histopathological examination. Pretreatment with O. ficus-indica extract attenuated the alteration in the measured parameters. It could be concluded that O. ficus-indica fruit peel extract can be regarded as a potential agent in limiting colonic complications due to irradiation, possibly by its antioxidant and anti-inflammatory properties.


Assuntos
Colite/prevenção & controle , Colo/efeitos da radiação , Opuntia/química , Extratos Vegetais/uso terapêutico , Protetores contra Radiação/isolamento & purificação , Animais , Colite/etiologia , Colite/patologia , Colo/efeitos dos fármacos , Colo/patologia , Feminino , Frutas/química , Cromatografia Gasosa-Espectrometria de Massas , Fitoterapia , Extratos Vegetais/isolamento & purificação , Profilaxia Pré-Exposição , Protetores contra Radiação/uso terapêutico , Ratos , Ratos Wistar
11.
Clin Exp Pharmacol Physiol ; 46(12): 1124-1132, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31357226

RESUMO

Cardiovascular disease is one of the most pivotal disorders after radiotherapy. The aim of this study investigates the possible protective effect of metformin against gamma radiation-induced heart damage in male rats. Group 1 (control) received saline, group 2 was whole body gamma-irradiated 5 Gy, group 3 was orally administered metformin 50 mg/kg/day for 2 weeks, group 4 received metformin 50 mg/kg/day for 1 week, then exposed to whole-body gamma radiation at a dose of 5 Gy and continued with metformin for further 1 week. The results revealed that the administration of metformin to irradiated rats significantly ameliorated the changes in cardiac biomarkers (LDH and CK-MB) compared with irradiated group. Heart catalase and SOD activities showed normal level when compared with the irradiated group. Also, NF-κB, IL-6 and TNF- α levels were markedly decreased compared with the corresponding values of irradiated group. Consequently, metformin reduced E-selectin as well ICAM and VCAM-1. These results confirmed by histopathological examination. In conclusion, concomitant administration of metformin during radiotherapy acts as a potent heart protector from oxidative stress, inflammatory mediators and endothelial dysfunction induced damages. Results thus hold a great promise for a new implication of an antidiabetic drug (metformin) as adjunct to radiotherapy.


Assuntos
Endotélio Vascular/efeitos dos fármacos , Coração/efeitos dos fármacos , Coração/fisiopatologia , Inflamação/patologia , Metformina/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Lesões Experimentais por Radiação , Animais , Catalase/metabolismo , Endotélio Vascular/metabolismo , Endotélio Vascular/fisiopatologia , Raios gama , Inflamação/tratamento farmacológico , Inflamação/etiologia , Inflamação/metabolismo , Masculino , Metformina/uso terapêutico , Miocárdio/metabolismo , Miocárdio/patologia , NF-kappa B/metabolismo , Lesões Experimentais por Radiação/complicações , Lesões Experimentais por Radiação/tratamento farmacológico , Lesões Experimentais por Radiação/metabolismo , Lesões Experimentais por Radiação/patologia , Ratos
12.
Free Radic Res ; 53(7): 748-757, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31146611

RESUMO

Hepatic irradiation during radiotherapy is associated with liver damage. The current study was designed to investigate the possible modulatory effects of pioglitazone against γ irradiation-induced hepatic damage in rats. Animals were exposed to a single dose of 6 Gy and received pioglitazone (10 mg/kg/day) orally for 4 weeks starting on the same day of irradiation. Results showed that irradiation increased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities as well as serum triglyceride (TG) and total cholesterol (TC) levels. Furthermore, it elevated inflammatory mediators; tumour necrosis factor alpha (TNF-α), interleukin-6 (IL-6); nuclear factor kappa B (NF-κB) and inducible nitric oxide synthase (iNOS) in hepatic tissues. Moreover, it increased levels of serum fibrotic markers; hyaluronic acid (HA), laminin (LN), and type III procollagen (PCIII). Additionally, hepatic fibrotic markers; transforming growth factor-ß1 (TGF-ß1) and hydroxyproline (HP) levels were elevated. Histological analysis of H&E and MT staining of liver sections exhibited cellular infiltration and fibrous deposition in irradiated rats. It was observed that pioglitazone modulated the described deviations. In conclusion, pioglitazone could serve as a promising therapeutic tool for attenuating radiation-induced liver injury in patients with radiotherapy which might be attributed to its anti-inflammatory and antifibrotic activities.


Assuntos
Anti-Inflamatórios/uso terapêutico , Fibroblastos/metabolismo , Hipoglicemiantes/uso terapêutico , Hepatopatias/tratamento farmacológico , Pioglitazona/uso terapêutico , Animais , Anti-Inflamatórios/farmacologia , Hipoglicemiantes/farmacologia , Masculino , Pioglitazona/farmacologia , Ratos , Transdução de Sinais
13.
Drug Deliv Transl Res ; 8(3): 525-535, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29313295

RESUMO

In the present study, L-arginine/acrylic acid (Arg/AAc) batch hydrogel was successfully prepared by gamma irradiation for transdermal delivery of propranolol HCl in hypertensive rats. The resulted system has been characterized by FTIR to confirm the hydrogel formation. The swelling behavior of the prepared hydrogels was investigated as a function of time and pH. The kinetics of swelling has been investigated. In vivo pharmacokinetics evaluation, skin irritation test, and histopathological studies were investigated. Furthermore, the antihypertensive efficacy of transdermal propranolol-loaded Arg/AAc hydrogel on methyl prednisolone acetate-induced hypertensive rats was evaluated. It was found that the prepared patches exhibited a sustained release of the drug into systemic circulation over oral route which is subjected to hepatic first-pass metabolism, coupled with a short plasma half-life. Transdermal administration displayed a prolonged antihypertensive effect in spontaneously hypertensive rats. Moreover, the skin irritation test and histopathological examination indicated that the prepared patches are not irritant and can be safely applied on the skin. These results indicated that the hydrogel system composed of Arg and AAc has potential as a transdermal delivery system.


Assuntos
Acrilatos/administração & dosagem , Anti-Hipertensivos/administração & dosagem , Arginina/administração & dosagem , Hidrogéis/administração & dosagem , Propranolol/administração & dosagem , Acrilatos/química , Acrilatos/farmacocinética , Acrilatos/uso terapêutico , Administração Cutânea , Animais , Anti-Hipertensivos/química , Anti-Hipertensivos/farmacocinética , Anti-Hipertensivos/uso terapêutico , Arginina/química , Arginina/farmacocinética , Arginina/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Liberação Controlada de Fármacos , Feminino , Raios gama , Hidrogéis/química , Hidrogéis/farmacocinética , Hidrogéis/uso terapêutico , Hipertensão/induzido quimicamente , Hipertensão/tratamento farmacológico , Metilprednisolona/análogos & derivados , Acetato de Metilprednisolona , Propranolol/química , Propranolol/farmacocinética , Propranolol/uso terapêutico , Ratos , Pele/anatomia & histologia , Pele/efeitos dos fármacos , Testes de Irritação da Pele , Adesivo Transdérmico
14.
J Photochem Photobiol B ; 178: 447-456, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29216568

RESUMO

Stem cell transplantation is a novel strategy for regenerative medicine in liver disease. This study was conducted to explore the modulatory effect of Nigella sativa oil (NSO) on the therapeutic potential of mesenchymal stem cells (MSCs) against irradiation-induced liver damage in rats. Liver damage was induced by a total body exposure to a single dose of 7Gy. NSO (2mg/kg/day) was then given orally for 4 consecutive weeks starting 24h after irradiation with or without a single intravenous MSCs administration, then rats were sacrificed four weeks after exposure to γ radiation. Data revealed that irradiation elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities in serum, increased hepatic malondialdehyde (MDA) content and reduced hepatic superoxide dismutase (SOD) activity. Furthermore, it caused elevation in pro-inflammatory mediators such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) associated with reduction in anti-inflammatory cytokine interleukin-10 (IL-10) and it increased fibrogenic marker transforming growth factor-ß (TGF-ß) in liver tissues. It was observed that combined NSO/MSCs therapy provided more beneficial tissue repair comparable to MSCs alone as demonstrated by modulating the tested parameters. Finally, these results were confirmed by histopathological examination. In conclusion, dual therapy with NSO and MSCs could serve as a promising approach for alleviating radiation-induced liver injury in patients with radiotherapy.


Assuntos
Hepatopatias/terapia , Transplante de Células-Tronco Mesenquimais , Óleos de Plantas/química , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Células da Medula Óssea/citologia , Células Cultivadas , Ensaio de Imunoadsorção Enzimática , Interleucina-10/análise , Interleucina-6/análise , Fígado/efeitos dos fármacos , Fígado/patologia , Fígado/efeitos da radiação , Masculino , Malondialdeído/metabolismo , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/metabolismo , Microscopia de Fluorescência , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/efeitos da radiação , Óleos de Plantas/farmacologia , Ratos , Superóxido Dismutase/metabolismo , Fator de Necrose Tumoral alfa/análise , Irradiação Corporal Total
15.
Drug Deliv Transl Res ; 8(1): 191-203, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29280061

RESUMO

In an effort to increase the oral bioavailability of Amphotericin B (AmB), a pH-sensitive drug carrier composed of Tragacanth (Trag) and acrylic acid (AAc) was prepared using γ-irradiation. The swelling behavior of (Trag/AAc) hydrogels was characterized as a function of pH and ionic strength of the swelling medium. The obtained swelling indices revealed the ability of the prepared hydrogel to protect a loaded drug in stomach-simulated medium (Fickian behavior) and to release such drug in intestinal-simulated medium (non-Fickian behavior). In vitro release studies of the antifungal (AmB) were performed to evaluate the hydrogel potential as a drug carrier. The antifungal activity of the prepared oral formulation was investigated in a mouse model of systemic candidiasis. Data revealed that (Trag/AAc)-AmB has a potent antifungal efficacy as demonstrated by prolonging the survival time and reducing the tissue fungal burden, serum antibody titers, as well as inflammatory cytokines in kidney and liver tissues. Furthermore, in vivo toxicity of (Trag/AAc)-AmB was assessed via measuring kidney and liver functions, and results displayed the safety of this novel AmB formulation which was confirmed by histopathological examination. Overall, results indicated that the prepared (Trag/AAc)-AmB is an effective oral delivery system for AmB with better bioavailability and minimal toxicity and could represent a promising approach for improving the therapeutic index of the drug.


Assuntos
Acrilatos/administração & dosagem , Anfotericina B/administração & dosagem , Antifúngicos/administração & dosagem , Candidíase/tratamento farmacológico , Portadores de Fármacos/administração & dosagem , Hidrogéis/administração & dosagem , Tragacanto/administração & dosagem , Acrilatos/química , Acrilatos/toxicidade , Administração Oral , Anfotericina B/química , Anfotericina B/toxicidade , Animais , Anticorpos Antifúngicos/sangue , Antifúngicos/química , Antifúngicos/toxicidade , Candida albicans/efeitos dos fármacos , Candida albicans/crescimento & desenvolvimento , Candida albicans/imunologia , Candidíase/sangue , Candidíase/imunologia , Candidíase/microbiologia , Citocinas/imunologia , Portadores de Fármacos/química , Portadores de Fármacos/toxicidade , Liberação Controlada de Fármacos , Hidrogéis/química , Hidrogéis/toxicidade , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Rim/efeitos dos fármacos , Rim/imunologia , Rim/microbiologia , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/imunologia , Fígado/microbiologia , Fígado/patologia , Masculino , Camundongos , Tragacanto/química , Tragacanto/toxicidade
16.
Chem Biol Interact ; 274: 68-79, 2017 Aug 25.
Artigo em Inglês | MEDLINE | ID: mdl-28693887

RESUMO

Fifteen novel 1,2,3-triazole derivatives were prepared in series of synthetic steps starting from 4-amino-5-hydrazino-4H-1,2,4-triazole-3-thiol 1. The structures of the obtained compounds were verified through micoanalytical and spectral data. All the compounds were screened for their anticancer activity against liver human cancer cell lines (HEPG2) using Doxorubicin as standard. The most promising triazolothiadiazine derivative 12 was further tested for its degree of toxicity by estimating the median lethal dose (LD 50) and its antitumor activity through inhibiting the angiogenesis and progression of tumor against diethylnitrosamine (DENA)/CCl4 induced hepatocellular carcinoma (HCC) in rats. To elucidate its mechanism of action, the following parameters were determined including: vascular endothelial growth factor (VEGF) as a marker of angiogenesis; hepatic tyrosine kinase (HTK) as a marker for tumor growth; serum alpha fetoprotein (AFP) as a marker for hepatocarcinoma; aspartate and alanine aminotransferases (AST & ALT) as liver function test; malondialdehyde (MDA) and glutathione (GSH) as markers of antioxidant activity. Liver histopathological analysis was also evaluated. Carcinogenic rats showed drastic elevation in all investigated parameters accompanied by reduction in hepatic glutathione. Administration of compound 12 into rats after induction of experimental HCC, improved the biochemical changes induced by DENA/CCl4. These observations were supported by histopathological study of liver sections. It was concluded that triazolothiadiazine compound 12 could be promising anti HCC agent after more investigations on higher animals.


Assuntos
Antineoplásicos/toxicidade , Fígado/efeitos dos fármacos , Tiadiazóis/toxicidade , Triazóis/toxicidade , Alanina Transaminase/sangue , Animais , Antineoplásicos/química , Antineoplásicos/uso terapêutico , Aspartato Aminotransferases/sangue , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Dietilnitrosamina/toxicidade , Glutationa/metabolismo , Humanos , Fígado/metabolismo , Fígado/patologia , Testes de Função Hepática , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/tratamento farmacológico , Neoplasias Hepáticas Experimentais/patologia , Masculino , Malondialdeído , Ratos , Ratos Wistar , Relação Estrutura-Atividade , Tiadiazóis/síntese química , Tiadiazóis/uso terapêutico , Triazóis/síntese química , Triazóis/química , Triazóis/uso terapêutico , Fator A de Crescimento do Endotélio Vascular/metabolismo , alfa-Fetoproteínas/análise
17.
J Photochem Photobiol B ; 170: 70-78, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28395211

RESUMO

Doxorubicin (DOX) is a highly effective antineoplastic drug; however, the clinical use of DOX is limited by its dose dependent cardiotoxicity. This study was conducted to evaluate the cardioprotective effect of sea cucumber and valsartan against DOX-induced cardiotoxicity in rats. Also, the role of exposure to low dose γ radiation (LDR) on each of them was investigated, since LDR could suppress various reactive oxygen species-related diseases. Rats received DOX (2.5mg/kg, ip) in six equal injections over a period of 2weeks, sea cucumber (14.4mg/kg, p.o) and valsartan (30mg/kg, p.o) for 8 successive weeks. Exposure to LDR (0.5Gy) was performed one day prior to DOX. Results revealed that DOX administration elevated serum levels of aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK-MB) and troponin-I as well as increased cardiac lipid peroxide content and myeloperoxidase (MPO) activity. Additionally, it increased cardiac expressions of iNOS and caspase-3, accompanied by reduction in cardiac total protein and glutathione (GSH) contents. Treatment with sea cucumber or valsartan improved the cardiotoxicity of DOX. Their adjuvant therapy with LDR offers an additional benefit to the cardioprotection of the therapeutic drugs. These results confirmed by histopathological examination. In conclusion, sea cucumber and valsartan alone or combined with LDR attenuated DOX-induced cardiotoxicity via their antioxidant and anti-apoptotic activities and thus might be useful in the treatment of human patients under doxorubicin chemotherapy.


Assuntos
Antioxidantes/farmacologia , Apoptose/efeitos dos fármacos , Raios gama , Pepinos-do-Mar/química , Animais , Antioxidantes/química , Apoptose/efeitos da radiação , Aspartato Aminotransferases/sangue , Caspase 3/genética , Caspase 3/metabolismo , Creatina Quinase/sangue , Doxorrubicina/toxicidade , Glutationa/metabolismo , Cardiopatias/etiologia , Masculino , Miocárdio/metabolismo , Miocárdio/patologia , Óxido Nítrico Sintase Tipo II/genética , Óxido Nítrico Sintase Tipo II/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/efeitos da radiação , Peroxidase/metabolismo , Ratos , Espécies Reativas de Oxigênio/metabolismo , Pepinos-do-Mar/metabolismo , Troponina I/sangue , Valsartana/farmacologia
18.
J Photochem Photobiol B ; 169: 56-62, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28282556

RESUMO

Cisplatin has demonstrated high antitumor efficacy. However, nephrotoxicity is a dose-limiting factor in its clinical use. The present study was designed to investigate the protective effect of rutin and low dose of irradiation (LDR) on cisplatin-induced nephrotoxicity in rats. Rats received rutin (200mg/kg/day, p.o) for 10 consecutive days and subjected to LDR (0.5Gy) 1day prior to cisplatin. Intraperitoneal administration of single dose of cisplatin (7.5mg/kg) was used to induce nephrotoxicity. Data showed that cisplatin caused elevation in serum creatinine and urea, disturbance in blood count, elevation in gene expression of tumor necrosis factor alpha, nuclear factor kappa B, interleukin-1ß, caspase-3, mitochondrial cytochrome C and apoptosis-inducing factor in renal tissue. Moreover, it caused elevation in renal malondialdehyde accompanied by reduction in glutathione content. These effects were confirmed by histopathological examination. It was observed that LDR and rutin ameliorated the studied parameters. In conclusion, LDR could be considered as a novel approach for prophylaxis of cisplatin induced renal damage, also it augmented the nephroprotective effect of rutin via modulating the expression of inflammatory, oxidative stress and apoptotic mediators as well as histological changes in rats kidneys and hence might be valuable in improving the therapeutic index of cisplatin.


Assuntos
Cisplatino/efeitos adversos , Raios gama/uso terapêutico , Nefropatias/terapia , Rutina/farmacologia , Animais , Apoptose/efeitos dos fármacos , Inflamação/prevenção & controle , Nefropatias/induzido quimicamente , Nefropatias/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Substâncias Protetoras/farmacologia , Substâncias Protetoras/uso terapêutico , Ratos , Rutina/uso terapêutico
19.
Int J Radiat Biol ; 93(5): 553-560, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28067097

RESUMO

OBJECTIVE: Fibromyalgia is a prevalent disorder characterized by chronic widespread pain and complex symptoms. This study was conducted to investigate the potential therapeutic effect of low-dose irradiation (LDI) alone or in combination with duloxetine on the reserpine-induced fibromyalgia in rats. METHODS: Fibromyalgia was induced by administration of reserpine (1 mg/kg/s.c) for 3 consecutive days. Duloxetine (30 mg/kg, p.o) was administered 60 min before a forced swimming test (FST), and rats were exposed to a single dose of γ-radiation (0.5 Gy) 1 day before the FST. RESULTS: Reserpine significantly increased immobility time in the FST, decreased the amount of 5-hydroxytryptamine, dopamine, and norepinephrine in cerebral cortex. It also increased malondialdehyde and nitric oxide and reduced glutathione contents in brain tissue. LDI alone or combined with duloxetine completely antagonized reserpine-induced fibromyalgia as assessed by the measured parameters. One of the most significant findings in this study was that the therapeutic effect of duloxetine was more pronounced by its combination with LDI. A possible mechanism of action of LDI and duloxetine responsible for their therapeutic effect was discussed. CONCLUSION: On the basis of the presented evidences, it could be concluded that LDI alone or combined with duloxetine could be of value in the management of fibromyalgia.


Assuntos
Quimiorradioterapia/métodos , Cloridrato de Duloxetina/administração & dosagem , Fibromialgia/diagnóstico , Fibromialgia/terapia , Raios gama/uso terapêutico , Analgésicos/administração & dosagem , Animais , Fibromialgia/induzido quimicamente , Masculino , Dosagem Radioterapêutica , Ratos , Ratos Wistar , Reserpina , Resultado do Tratamento
20.
Int J Biol Macromol ; 92: 957-964, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27471091

RESUMO

The copolymerization of starch with acrylic acid AAc using direct gamma radiation technique was performed. The effect of AAc concentrations on the gel (%) and swelling behavior were investigated. It is found that as AAc concentrations increase both gel(%) and swelling behavior increase. The Poly(starch/acrylic acid) (1:10wt%) hydrogel were selected due to its high swelling properties. From the in-vitro release study of the rutin-loaded hydrogel it is observed that it is strong pH-dependent release behavior, thus offering a maximum release as pH increased. The dextran sulphate sodium (DSS)-induced rat colitis model was treated with rutin-loaded Poly(starch/acrylic acid) (1:10wt%) hydrogel and free rutin solution by oral administration. Colitic control group showed a significant elevation in colon/body weight ratio, myeloperoxgidase activity, tumor necrosis factor, nitric oxide and malondialdehyde levels. However, glutathione level was reduced. It was found that the rutin-loaded hydrogel was more efficient than free rutin as evidenced by improvement of all measured parameters. These effects were confirmed histopathologically and may be attributed to its ability to control delivery of rutin to colon with minor early release of rutin before colon. The Poly(starch/acrylic acid) (1:10wt%) can represent a pivotal anti-inflammatory approach for patients with inflammatory bowel disease in order to increase efficacy and reduce toxicity.


Assuntos
Resinas Acrílicas/síntese química , Raios gama , Hidrogel de Polietilenoglicol-Dimetacrilato/síntese química , Rutina/farmacologia , Amido/síntese química , Animais , Peso Corporal/efeitos dos fármacos , Colo/efeitos dos fármacos , Colo/patologia , Preparações de Ação Retardada , Concentração de Íons de Hidrogênio , Masculino , Tamanho do Órgão/efeitos dos fármacos , Ratos Wistar , Espectroscopia de Infravermelho com Transformada de Fourier , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA